産業情報サービスを提供する世界有力企業です。
メニュー
遺伝子組換えワクチンの世界市場レポート2024-2030
英文タイトル： Global Genetic Vaccine Market Insights, Forecast to 2030
- レポートID：24910
- 発表時期：2024-02-11
- 訪問回数：885
- ページ数：117
- レポート形式：PDF
- レポート言語：英語、日本語
- グラフ数：146
- レポートカテゴリ： 薬品及びサプリメント
販売価格（消費税別）
販売価格（消費税別）
個人版
詳細マルチユーザー版
詳細企業版
詳細
価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。
価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。
※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は、遺伝子組換えワクチンの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に遺伝子組換えワクチン市場を分類しています。本レポートでは世界の遺伝子組換えワクチン市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life Sciences、Medicago、Pukang Biologic Technology、Johnson & Johnson、Clover Biopharmaceuticals、Suzhou Yuzhibo Biotechnology、Novavax、CureVac、Arcturus Therapeutics、BioNTech、Takeda
レポートは遺伝子組換えワクチンの主要生産者を調査し、主要地域や国の消費状況も提供します。遺伝子組換えワクチンの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。
2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。タイプ別市場セグメント：
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の遺伝子組換えワクチン生産量、成長率、市場シェアを調査している。
Recombinant Protein Vaccine
Gene-Based Vaccine
用途別の市場セグメント：
Human
Animal
本レポートの詳細内容
本レポートは、世界の遺伝子組換えワクチン市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて遺伝子組換えワクチン市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
二. 消費面では、遺伝子組換えワクチンの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。
三.主要メーカーの遺伝子組換えワクチン売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の遺伝子組換えワクチン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。
四.本遺伝子組換えワクチンのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章の概要第1章：遺伝子組換えワクチンのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 遺伝子組換えワクチンの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける遺伝子組換えワクチンの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章遺伝子組換えワクチンメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：遺伝子組換えワクチンの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：遺伝子組換えワクチンの主要メーカーの概要を提供し、製品の説明と仕様、遺伝子組換えワクチンの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：遺伝子組換えワクチンの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。
概要
Gene vaccine refers to DNA vaccine, the gene encoding exogenous antigen is inserted into the plasmid containing eukaryotic expression system, and then the plasmid is directly introduced into the human or animal body, allowing it to express antigen protein in host cells and induce the immune response of the body.
The global Genetic Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Genetic Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Genetic Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Genetic Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Genetic Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Genetic Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Genetic Vaccine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Medicago
Pukang Biologic Technology
Johnson & Johnson
Clover Biopharmaceuticals
Suzhou Yuzhibo Biotechnology
Novavax
CureVac
Arcturus Therapeutics
BioNTech
Takeda
Segment by Type
Recombinant Protein Vaccine
Gene-Based Vaccine
Segment by Application
Human
Animal
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Genetic Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Genetic Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genetic Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.総目録
1 Study Coverage
1.1 Genetic Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Genetic Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Market by Application
1.3.1 Global Genetic Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Human
1.3.3 Animal
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Genetic Vaccine Sales Estimates and Forecasts 2019-2030
2.2 Global Genetic Vaccine Revenue by Region
2.2.1 Global Genetic Vaccine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Genetic Vaccine Revenue by Region (2019-2024)
2.2.3 Global Genetic Vaccine Revenue by Region (2025-2030)
2.2.4 Global Genetic Vaccine Revenue Market Share by Region (2019-2030)
2.3 Global Genetic Vaccine Sales Estimates and Forecasts 2019-2030
2.4 Global Genetic Vaccine Sales by Region
2.4.1 Global Genetic Vaccine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Genetic Vaccine Sales by Region (2019-2024)
2.4.3 Global Genetic Vaccine Sales by Region (2025-2030)
2.4.4 Global Genetic Vaccine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Genetic Vaccine Sales by Manufacturers
3.1.1 Global Genetic Vaccine Sales by Manufacturers (2019-2024)
3.1.2 Global Genetic Vaccine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Genetic Vaccine in 2023
3.2 Global Genetic Vaccine Revenue by Manufacturers
3.2.1 Global Genetic Vaccine Revenue by Manufacturers (2019-2024)
3.2.2 Global Genetic Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Genetic Vaccine Revenue in 2023
3.3 Global Key Players of Genetic Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Genetic Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Genetic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Genetic Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Genetic Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Genetic Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Genetic Vaccine Sales by Type
4.1.1 Global Genetic Vaccine Historical Sales by Type (2019-2024)
4.1.2 Global Genetic Vaccine Forecasted Sales by Type (2025-2030)
4.1.3 Global Genetic Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Genetic Vaccine Revenue by Type
4.2.1 Global Genetic Vaccine Historical Revenue by Type (2019-2024)
4.2.2 Global Genetic Vaccine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Genetic Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Genetic Vaccine Price by Type
4.3.1 Global Genetic Vaccine Price by Type (2019-2024)
4.3.2 Global Genetic Vaccine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Genetic Vaccine Sales by Application
5.1.1 Global Genetic Vaccine Historical Sales by Application (2019-2024)
5.1.2 Global Genetic Vaccine Forecasted Sales by Application (2025-2030)
5.1.3 Global Genetic Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Genetic Vaccine Revenue by Application
5.2.1 Global Genetic Vaccine Historical Revenue by Application (2019-2024)
5.2.2 Global Genetic Vaccine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Genetic Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Genetic Vaccine Price by Application
5.3.1 Global Genetic Vaccine Price by Application (2019-2024)
5.3.2 Global Genetic Vaccine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Genetic Vaccine Market Size by Type
6.1.1 US & Canada Genetic Vaccine Sales by Type (2019-2030)
6.1.2 US & Canada Genetic Vaccine Revenue by Type (2019-2030)
6.2 US & Canada Genetic Vaccine Market Size by Application
6.2.1 US & Canada Genetic Vaccine Sales by Application (2019-2030)
6.2.2 US & Canada Genetic Vaccine Revenue by Application (2019-2030)
6.3 US & Canada Genetic Vaccine Market Size by Country
6.3.1 US & Canada Genetic Vaccine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Genetic Vaccine Sales by Country (2019-2030)
6.3.3 US & Canada Genetic Vaccine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Genetic Vaccine Market Size by Type
7.1.1 Europe Genetic Vaccine Sales by Type (2019-2030)
7.1.2 Europe Genetic Vaccine Revenue by Type (2019-2030)
7.2 Europe Genetic Vaccine Market Size by Application
7.2.1 Europe Genetic Vaccine Sales by Application (2019-2030)
7.2.2 Europe Genetic Vaccine Revenue by Application (2019-2030)
7.3 Europe Genetic Vaccine Market Size by Country
7.3.1 Europe Genetic Vaccine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Genetic Vaccine Sales by Country (2019-2030)
7.3.3 Europe Genetic Vaccine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Genetic Vaccine Market Size
8.1.1 China Genetic Vaccine Sales (2019-2030)
8.1.2 China Genetic Vaccine Revenue (2019-2030)
8.2 China Genetic Vaccine Market Size by Application
8.2.1 China Genetic Vaccine Sales by Application (2019-2030)
8.2.2 China Genetic Vaccine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Genetic Vaccine Market Size by Type
9.1.1 Asia Genetic Vaccine Sales by Type (2019-2030)
9.1.2 Asia Genetic Vaccine Revenue by Type (2019-2030)
9.2 Asia Genetic Vaccine Market Size by Application
9.2.1 Asia Genetic Vaccine Sales by Application (2019-2030)
9.2.2 Asia Genetic Vaccine Revenue by Application (2019-2030)
9.3 Asia Genetic Vaccine Sales by Region
9.3.1 Asia Genetic Vaccine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Genetic Vaccine Revenue by Region (2019-2030)
9.3.3 Asia Genetic Vaccine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Genetic Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Genetic Vaccine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Genetic Vaccine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Genetic Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Genetic Vaccine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Genetic Vaccine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Genetic Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Genetic Vaccine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Genetic Vaccine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Genetic Vaccine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 GSK Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Sanofi Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Zoties
11.4.1 Zoties Company Information
11.4.2 Zoties Overview
11.4.3 Zoties Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Zoties Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zoties Recent Developments
11.5 Elanco
11.5.1 Elanco Company Information
11.5.2 Elanco Overview
11.5.3 Elanco Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Elanco Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Elanco Recent Developments
11.6 Boehringer-Ingelheim
11.6.1 Boehringer-Ingelheim Company Information
11.6.2 Boehringer-Ingelheim Overview
11.6.3 Boehringer-Ingelheim Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Boehringer-Ingelheim Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer-Ingelheim Recent Developments
11.7 Indian Immunologicals
11.7.1 Indian Immunologicals Company Information
11.7.2 Indian Immunologicals Overview
11.7.3 Indian Immunologicals Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Indian Immunologicals Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Indian Immunologicals Recent Developments
11.8 Plumbline Life Sciences
11.8.1 Plumbline Life Sciences Company Information
11.8.2 Plumbline Life Sciences Overview
11.8.3 Plumbline Life Sciences Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Plumbline Life Sciences Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Plumbline Life Sciences Recent Developments
11.9 Medicago
11.9.1 Medicago Company Information
11.9.2 Medicago Overview
11.9.3 Medicago Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Medicago Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Medicago Recent Developments
11.10 Pukang Biologic Technology
11.10.1 Pukang Biologic Technology Company Information
11.10.2 Pukang Biologic Technology Overview
11.10.3 Pukang Biologic Technology Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Pukang Biologic Technology Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pukang Biologic Technology Recent Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Information
11.11.2 Johnson & Johnson Overview
11.11.3 Johnson & Johnson Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Johnson & Johnson Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Johnson & Johnson Recent Developments
11.12 Clover Biopharmaceuticals
11.12.1 Clover Biopharmaceuticals Company Information
11.12.2 Clover Biopharmaceuticals Overview
11.12.3 Clover Biopharmaceuticals Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Clover Biopharmaceuticals Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Clover Biopharmaceuticals Recent Developments
11.13 Suzhou Yuzhibo Biotechnology
11.13.1 Suzhou Yuzhibo Biotechnology Company Information
11.13.2 Suzhou Yuzhibo Biotechnology Overview
11.13.3 Suzhou Yuzhibo Biotechnology Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Suzhou Yuzhibo Biotechnology Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Suzhou Yuzhibo Biotechnology Recent Developments
11.14 Novavax
11.14.1 Novavax Company Information
11.14.2 Novavax Overview
11.14.3 Novavax Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Novavax Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Novavax Recent Developments
11.15 CureVac
11.15.1 CureVac Company Information
11.15.2 CureVac Overview
11.15.3 CureVac Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 CureVac Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 CureVac Recent Developments
11.16 Arcturus Therapeutics
11.16.1 Arcturus Therapeutics Company Information
11.16.2 Arcturus Therapeutics Overview
11.16.3 Arcturus Therapeutics Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Arcturus Therapeutics Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Arcturus Therapeutics Recent Developments
11.17 BioNTech
11.17.1 BioNTech Company Information
11.17.2 BioNTech Overview
11.17.3 BioNTech Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 BioNTech Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 BioNTech Recent Developments
11.18 Takeda
11.18.1 Takeda Company Information
11.18.2 Takeda Overview
11.18.3 Takeda Genetic Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.18.4 Takeda Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Takeda Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Genetic Vaccine Industry Chain Analysis
12.2 Genetic Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Genetic Vaccine Production Mode & Process
12.4 Genetic Vaccine Sales and Marketing
12.4.1 Genetic Vaccine Sales Channels
12.4.2 Genetic Vaccine Distributors
12.5 Genetic Vaccine Customers
13 Market Dynamics
13.1 Genetic Vaccine Industry Trends
13.2 Genetic Vaccine Market Drivers
13.3 Genetic Vaccine Market Challenges
13.4 Genetic Vaccine Market Restraints
14 Key Findings in The Global Genetic Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
表と図のリスト
List of Tables
Table 1. Global Genetic Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Recombinant Protein Vaccine
Table 3. Major Manufacturers of Gene-Based Vaccine
Table 4. Global Genetic Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Genetic Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Genetic Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Genetic Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Genetic Vaccine Revenue Market Share by Region (2019-2024)
Table 9. Global Genetic Vaccine Revenue Market Share by Region (2025-2030)
Table 10. Global Genetic Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Genetic Vaccine Sales by Region (2019-2024) & (K Doses)
Table 12. Global Genetic Vaccine Sales by Region (2025-2030) & (K Doses)
Table 13. Global Genetic Vaccine Sales Market Share by Region (2019-2024)
Table 14. Global Genetic Vaccine Sales Market Share by Region (2025-2030)
Table 15. Global Genetic Vaccine Sales by Manufacturers (2019-2024) & (K Doses)
Table 16. Global Genetic Vaccine Sales Share by Manufacturers (2019-2024)
Table 17. Global Genetic Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Genetic Vaccine Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Genetic Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Genetic Vaccine Price by Manufacturers 2019-2024 (US$/Dose)
Table 21. Global Genetic Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Genetic Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Vaccine as of 2023)
Table 23. Global Key Manufacturers of Genetic Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Genetic Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Genetic Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Genetic Vaccine Sales by Type (2019-2024) & (K Doses)
Table 28. Global Genetic Vaccine Sales by Type (2025-2030) & (K Doses)
Table 29. Global Genetic Vaccine Sales Share by Type (2019-2024)
Table 30. Global Genetic Vaccine Sales Share by Type (2025-2030)
Table 31. Global Genetic Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Genetic Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Genetic Vaccine Revenue Share by Type (2019-2024)
Table 34. Global Genetic Vaccine Revenue Share by Type (2025-2030)
Table 35. Genetic Vaccine Price by Type (2019-2024) & (US$/Dose)
Table 36. Global Genetic Vaccine Price Forecast by Type (2025-2030) & (US$/Dose)
Table 37. Global Genetic Vaccine Sales by Application (2019-2024) & (K Doses)
Table 38. Global Genetic Vaccine Sales by Application (2025-2030) & (K Doses)
Table 39. Global Genetic Vaccine Sales Share by Application (2019-2024)
Table 40. Global Genetic Vaccine Sales Share by Application (2025-2030)
Table 41. Global Genetic Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Genetic Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Genetic Vaccine Revenue Share by Application (2019-2024)
Table 44. Global Genetic Vaccine Revenue Share by Application (2025-2030)
Table 45. Genetic Vaccine Price by Application (2019-2024) & (US$/Dose)
Table 46. Global Genetic Vaccine Price Forecast by Application (2025-2030) & (US$/Dose)
Table 47. US & Canada Genetic Vaccine Sales by Type (2019-2024) & (K Doses)
Table 48. US & Canada Genetic Vaccine Sales by Type (2025-2030) & (K Doses)
Table 49. US & Canada Genetic Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Genetic Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Genetic Vaccine Sales by Application (2019-2024) & (K Doses)
Table 52. US & Canada Genetic Vaccine Sales by Application (2025-2030) & (K Doses)
Table 53. US & Canada Genetic Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Genetic Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Genetic Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Genetic Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Genetic Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Genetic Vaccine Sales by Country (2019-2024) & (K Doses)
Table 59. US & Canada Genetic Vaccine Sales by Country (2025-2030) & (K Doses)
Table 60. Europe Genetic Vaccine Sales by Type (2019-2024) & (K Doses)
Table 61. Europe Genetic Vaccine Sales by Type (2025-2030) & (K Doses)
Table 62. Europe Genetic Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Genetic Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Genetic Vaccine Sales by Application (2019-2024) & (K Doses)
Table 65. Europe Genetic Vaccine Sales by Application (2025-2030) & (K Doses)
Table 66. Europe Genetic Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Genetic Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Genetic Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Genetic Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Genetic Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Genetic Vaccine Sales by Country (2019-2024) & (K Doses)
Table 72. Europe Genetic Vaccine Sales by Country (2025-2030) & (K Doses)
Table 73. China Genetic Vaccine Sales by Type (2019-2024) & (K Doses)
Table 74. China Genetic Vaccine Sales by Type (2025-2030) & (K Doses)
Table 75. China Genetic Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Genetic Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Genetic Vaccine Sales by Application (2019-2024) & (K Doses)
Table 78. China Genetic Vaccine Sales by Application (2025-2030) & (K Doses)
Table 79. China Genetic Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Genetic Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Genetic Vaccine Sales by Type (2019-2024) & (K Doses)
Table 82. Asia Genetic Vaccine Sales by Type (2025-2030) & (K Doses)
Table 83. Asia Genetic Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Genetic Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Genetic Vaccine Sales by Application (2019-2024) & (K Doses)
Table 86. Asia Genetic Vaccine Sales by Application (2025-2030) & (K Doses)
Table 87. Asia Genetic Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Genetic Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Genetic Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Genetic Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Genetic Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Genetic Vaccine Sales by Region (2019-2024) & (K Doses)
Table 93. Asia Genetic Vaccine Sales by Region (2025-2030) & (K Doses)
Table 94. Middle East, Africa and Latin America Genetic Vaccine Sales by Type (2019-2024) & (K Doses)
Table 95. Middle East, Africa and Latin America Genetic Vaccine Sales by Type (2025-2030) & (K Doses)
Table 96. Middle East, Africa and Latin America Genetic Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Genetic Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Genetic Vaccine Sales by Application (2019-2024) & (K Doses)
Table 99. Middle East, Africa and Latin America Genetic Vaccine Sales by Application (2025-2030) & (K Doses)
Table 100. Middle East, Africa and Latin America Genetic Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Genetic Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Genetic Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Genetic Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Genetic Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Genetic Vaccine Sales by Country (2019-2024) & (K Doses)
Table 106. Middle East, Africa and Latin America Genetic Vaccine Sales by Country (2025-2030) & (K Doses)
Table 107. Merck Company Information
Table 108. Merck Description and Major Businesses
Table 109. Merck Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 110. Merck Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 115. GSK Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 120. Sanofi Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Zoties Company Information
Table 123. Zoties Description and Major Businesses
Table 124. Zoties Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 125. Zoties Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Zoties Recent Developments
Table 127. Elanco Company Information
Table 128. Elanco Description and Major Businesses
Table 129. Elanco Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 130. Elanco Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Elanco Recent Developments
Table 132. Boehringer-Ingelheim Company Information
Table 133. Boehringer-Ingelheim Description and Major Businesses
Table 134. Boehringer-Ingelheim Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 135. Boehringer-Ingelheim Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Boehringer-Ingelheim Recent Developments
Table 137. Indian Immunologicals Company Information
Table 138. Indian Immunologicals Description and Major Businesses
Table 139. Indian Immunologicals Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 140. Indian Immunologicals Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Indian Immunologicals Recent Developments
Table 142. Plumbline Life Sciences Company Information
Table 143. Plumbline Life Sciences Description and Major Businesses
Table 144. Plumbline Life Sciences Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 145. Plumbline Life Sciences Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Plumbline Life Sciences Recent Developments
Table 147. Medicago Company Information
Table 148. Medicago Description and Major Businesses
Table 149. Medicago Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 150. Medicago Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Medicago Recent Developments
Table 152. Pukang Biologic Technology Company Information
Table 153. Pukang Biologic Technology Description and Major Businesses
Table 154. Pukang Biologic Technology Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 155. Pukang Biologic Technology Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Pukang Biologic Technology Recent Developments
Table 157. Johnson & Johnson Company Information
Table 158. Johnson & Johnson Description and Major Businesses
Table 159. Johnson & Johnson Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 160. Johnson & Johnson Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Johnson & Johnson Recent Developments
Table 162. Clover Biopharmaceuticals Company Information
Table 163. Clover Biopharmaceuticals Description and Major Businesses
Table 164. Clover Biopharmaceuticals Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 165. Clover Biopharmaceuticals Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Clover Biopharmaceuticals Recent Developments
Table 167. Suzhou Yuzhibo Biotechnology Company Information
Table 168. Suzhou Yuzhibo Biotechnology Description and Major Businesses
Table 169. Suzhou Yuzhibo Biotechnology Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 170. Suzhou Yuzhibo Biotechnology Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Suzhou Yuzhibo Biotechnology Recent Developments
Table 172. Novavax Company Information
Table 173. Novavax Description and Major Businesses
Table 174. Novavax Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 175. Novavax Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Novavax Recent Developments
Table 177. CureVac Company Information
Table 178. CureVac Description and Major Businesses
Table 179. CureVac Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 180. CureVac Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. CureVac Recent Developments
Table 182. Arcturus Therapeutics Company Information
Table 183. Arcturus Therapeutics Description and Major Businesses
Table 184. Arcturus Therapeutics Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 185. Arcturus Therapeutics Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Arcturus Therapeutics Recent Developments
Table 187. BioNTech Company Information
Table 188. BioNTech Description and Major Businesses
Table 189. BioNTech Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 190. BioNTech Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. BioNTech Recent Developments
Table 192. Takeda Company Information
Table 193. Takeda Description and Major Businesses
Table 194. Takeda Genetic Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 195. Takeda Genetic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Takeda Recent Developments
Table 197. Key Raw Materials Lists
Table 198. Raw Materials Key Suppliers Lists
Table 199. Genetic Vaccine Distributors List
Table 200. Genetic Vaccine Customers List
Table 201. Genetic Vaccine Market Trends
Table 202. Genetic Vaccine Market Drivers
Table 203. Genetic Vaccine Market Challenges
Table 204. Genetic Vaccine Market Restraints
Table 205. Research Programs/Design for This Report
Table 206. Key Data Information from Secondary Sources
Table 207. Key Data Information from Primary Sources
List of Figures
Figure 1. Genetic Vaccine Product Picture
Figure 2. Global Genetic Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Genetic Vaccine Market Share by Type in 2023 & 2030
Figure 4. Recombinant Protein Vaccine Product Picture
Figure 5. Gene-Based Vaccine Product Picture
Figure 6. Global Genetic Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Genetic Vaccine Market Share by Application in 2023 & 2030
Figure 8. Human
Figure 9. Animal
Figure 10. Genetic Vaccine Report Years Considered
Figure 11. Global Genetic Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Genetic Vaccine Revenue 2019-2030 (US$ Million)
Figure 13. Global Genetic Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Genetic Vaccine Revenue Market Share by Region (2019-2030)
Figure 15. Global Genetic Vaccine Sales 2019-2030 ((K Doses)
Figure 16. Global Genetic Vaccine Sales Market Share by Region (2019-2030)
Figure 17. US & Canada Genetic Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 18. US & Canada Genetic Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Genetic Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 20. Europe Genetic Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Genetic Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 22. China Genetic Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) Genetic Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 24. Asia (excluding China) Genetic Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Genetic Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 26. Middle East, Africa and Latin America Genetic Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Genetic Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of Genetic Vaccine in the World: Market Share by Genetic Vaccine Revenue in 2023
Figure 29. Global Genetic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Genetic Vaccine Sales Market Share by Type (2019-2030)
Figure 31. Global Genetic Vaccine Revenue Market Share by Type (2019-2030)
Figure 32. Global Genetic Vaccine Sales Market Share by Application (2019-2030)
Figure 33. Global Genetic Vaccine Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada Genetic Vaccine Sales Market Share by Type (2019-2030)
Figure 35. US & Canada Genetic Vaccine Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada Genetic Vaccine Sales Market Share by Application (2019-2030)
Figure 37. US & Canada Genetic Vaccine Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Genetic Vaccine Revenue Share by Country (2019-2030)
Figure 39. US & Canada Genetic Vaccine Sales Share by Country (2019-2030)
Figure 40. U.S. Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 41. Canada Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 42. Europe Genetic Vaccine Sales Market Share by Type (2019-2030)
Figure 43. Europe Genetic Vaccine Revenue Market Share by Type (2019-2030)
Figure 44. Europe Genetic Vaccine Sales Market Share by Application (2019-2030)
Figure 45. Europe Genetic Vaccine Revenue Market Share by Application (2019-2030)
Figure 46. Europe Genetic Vaccine Revenue Share by Country (2019-2030)
Figure 47. Europe Genetic Vaccine Sales Share by Country (2019-2030)
Figure 48. Germany Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 49. France Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 50. U.K. Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 51. Italy Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. Russia Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. China Genetic Vaccine Sales Market Share by Type (2019-2030)
Figure 54. China Genetic Vaccine Revenue Market Share by Type (2019-2030)
Figure 55. China Genetic Vaccine Sales Market Share by Application (2019-2030)
Figure 56. China Genetic Vaccine Revenue Market Share by Application (2019-2030)
Figure 57. Asia Genetic Vaccine Sales Market Share by Type (2019-2030)
Figure 58. Asia Genetic Vaccine Revenue Market Share by Type (2019-2030)
Figure 59. Asia Genetic Vaccine Sales Market Share by Application (2019-2030)
Figure 60. Asia Genetic Vaccine Revenue Market Share by Application (2019-2030)
Figure 61. Asia Genetic Vaccine Revenue Share by Region (2019-2030)
Figure 62. Asia Genetic Vaccine Sales Share by Region (2019-2030)
Figure 63. Japan Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 64. South Korea Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 65. China Taiwan Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 67. India Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Genetic Vaccine Sales Market Share by Type (2019-2030)
Figure 69. Middle East, Africa and Latin America Genetic Vaccine Revenue Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Genetic Vaccine Sales Market Share by Application (2019-2030)
Figure 71. Middle East, Africa and Latin America Genetic Vaccine Revenue Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Genetic Vaccine Revenue Share by Country (2019-2030)
Figure 73. Middle East, Africa and Latin America Genetic Vaccine Sales Share by Country (2019-2030)
Figure 74. Brazil Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 75. Mexico Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 76. Turkey Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 77. Israel Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 78. GCC Countries Genetic Vaccine Revenue (2019-2030) & (US$ Million)
Figure 79. Genetic Vaccine Value Chain
Figure 80. Genetic Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
以下、関連資料のご紹介
01. サンプル提供
ご購入前にサンプル（英語、日本語）が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能；基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期：英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込（納品後、ご請求書送付）。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合：
レポート選択
見積もり依頼
メールでのご注文
入手（英語版は2〜4営業日、日本語版は8〜10営業日）
決済（後払い）
クレジットカード決済の場合：
レポート選択
ウェブサイトでのご注文
決済
入手（英語版は2〜4営業日、日本語版は8〜10営業日）
ご利用ガイド
関連リンク
お電話でのお問い合わせ
9:00-18:00 (土日・祝日を除く)
